Table 1.
A clinical randomized controlled Neurofeedback study with 91 participants
| |
|
|
|
Neurofeedback + |
|
|---|---|---|---|---|---|
| |
Total |
Medication |
Medication |
Neurofeedback |
|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | p-value | |
|
Demografics | |||||
| Children participating1 |
91 (100 %) |
31 (34 %) |
30 (33 %) |
30 (33 %) |
|
| Sex (boys)1 |
72 (80 %) |
27 (87 %) |
23 (77 %) |
22 (73 %) |
0.514 |
| Age |
11.2 (2.8) |
10.9 (2.4) |
11.2 (2.8) |
11.4 (3.1) |
0.772 |
| IQ |
87 (14) |
87 (15) |
85 (13) |
89 (14) |
0.752 |
|
ADHD core symptoms3 | |||||
| Total |
34.1 (8.9) |
35.8 (10.8) |
33.8 (7.8) |
32.6 (7.7) |
0.392 |
| Attention |
16.7 (4.7) |
17.4 (5.1) |
17.2 (4.9) |
15.5 (4.0) |
0.222 |
| Hyperactivity | 17.3 (5.2) | 18.2 (6.2) | 16.5 (4.9) | 17.1 (4.5) | 0.472 |
1 Number (%).2 ANOVA for the null-hypotheses that the values for the randomized groups are equal. 3 Barkley rating scale based on parents score. 4 Exact χ2−–test.